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Background: Currently, up to 85% of the oral resection specimens have inadequate resection margins, of
which the majority is located in the deeper soft tissue layers. The prognosis of patients with oral cavity
squamous cell carcinoma (OCSCC) of the tongue is negatively affected by these inadequate surgical resec-
tions. Raman spectroscopy, an optical technique, can potentially be used for intra-operative evaluation of
resection margins.
Objective: To develop in vitro Raman spectroscopy-based tissue classification models that discriminate
OCSCC of the tongue from (subepithelial) non-tumorous tissue.
Materials and methods: Tissue classification models were developed using Principal Components Analysis
(PCA) followed by (hierarchical) Linear Discriminant Analysis ((h)LDA). The models were based on a
training set of 720 histopathologically annotated Raman spectra, obtained from 25 tongue samples
(11 OCSCC and 14 normal) of 10 patients, and were validated by means of an independent validation
set of 367 spectra, obtained from 19 tongue samples (6 OCSCC and 13 normal) of 11 patients.
Results: A PCA-LDA tissue classification model ‘tumor’ versus ‘non-tumorous tissue’ (i.e. surface squa-
mous epithelium, connective tissue, muscle, adipose tissue, gland and nerve) showed an accuracy of
86% (sensitivity: 100%, specificity: 66%). A two-step PCA-hLDA tissue classification model ‘tumor’ versus
‘non-tumorous tissue’ showed an accuracy of 91% (sensitivity: 100%, specificity: 78%).
Conclusion: An accurate PCA-hLDA Raman spectroscopy-based tissue classification model for discrimina-
tion between OCSCC and (especially the subepithelial) non-tumorous tongue tissue was developed and
validated. This model with high sensitivity and specificity may prove to be very helpful to detect tumor
in the resection margins.
 2016 Erasmus MC Rotterdam. Published by Elsevier Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).Introduction
Every year 300,000 new cases of oral cavity squamous cell
carcinomas (OCSCCs) are diagnosed worldwide [1] and only half
of these patientswill survive 5 years [2]. The prognosis is negatively
affected by inadequate surgical resections [3–5]. Nevertheless, it
was recently shown that in current practice up to 85% of the oral
resection specimens have inadequate resection margins (65 mm
distance between tumor border and resection surface) [3,4].
During operation, the surgeon attempts to define the borders of
the tumor by visual inspection and palpation. Additionally, a
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histopathological examination of suspicious regions [6]. However,
the diagnostic accuracy of the frozen section procedure depends
on how well the sampled tissue represents the actual resection
margin that is suspected to be inadequate [7]. Since in oral cavity
up to 87% of all tumor-positive margins are located in the deeper
soft tissue layers [8], the common practice of taking samples of
the epithelial margin is of limited value. Moreover, the sampling
error is often inevitable because only a small portion of the
resection margins can be evaluated by frozen sections, due to the
fact that the procedure is too time-consuming and laborious [9].
Thus, an intra-operative tool that provides a real-time and
objective evaluation of all resection margins (especially in the dee-
per soft tissue margins) may increase the number of adequate
resections and thereby improve the prognosis of patients with
OCSCC.
Raman spectroscopy is an optical technique that is suited for
such intra-operative use because it is nondestructive and no pre-
treatment or labeling of the tissue is needed [10]. The technique
is based on inelastic scattering of light by molecules [11]. A Raman
spectrum contains characteristic peaks that are assigned to a corre-
sponding molecular structure within the illuminated tissue. Thus,
Raman spectroscopy enables tissue characterization based on
objective molecular information [12]. Because of these attractive
properties, there has been much interest in the use of Raman spec-
troscopy for differentiation between tumor and non-tumorous tis-
sue [13–16] in the head and neck region [17–20], including the oral
cavity [21–27].
Tongue, which is the most common subsite of OCSCC [28], com-
prises different histological structures and layers [29], all having
their own specific Raman spectroscopic features. In order to pro-
vide a tool that detects OCSCC within the surrounding non-
tumorous tongue tissue, a good understanding of all histological
structures and their spectroscopic features is needed. Histopatho-
logically annotated Raman spectra were used in our previous work
[30] to enable distinction between OCSCC of the tongue and indi-
vidual tissue structures, including those in the deeper soft tissue.
Due to the large differences in lipid-protein ratio, a 100% accurate
distinction was possible between OCSCC and adipose tissue, and
OCSCC and nerve. Although the other deeper located healthy tissue
structures (connective tissue (CT), gland and muscle) had a greater
spectral similarity to the OCSCC spectrum, these structures were
also spectrally distinguishable from OCSCC with high accuracy
(93%, 94%, and 97% respectively). Furthermore, as might be
expected by similarities in biochemical composition, the spectral
features of OCSCC and surface squamous epithelium (i.e. non-
tumorous squamous epithelium covering the surface of the ton-
gue) were partly overlapping, resulting in a lower discriminatory
power of 75% [30].
The objective of our current study was to prove the potential of
Raman spectroscopy in discriminating OCSCC from non-tumorous
tongue tissue, by developing in vitro tissue classification models
based on spectral data of individual non-tumorous tissue struc-
tures. The accuracy of the models was validated by means of an
independent dataset.Materials and methods
Sample handling and sample preparation
At the department of Otorhinolaryngology and Head and Neck
Surgery of the Erasmus MC Cancer Institute, University Medical
Center Rotterdam, 44 tissue samples were collected from 21
patients who had undergone a surgical resection because of a pri-
mary OCSCC of the tongue. Informed consent was obtained prior tothe operation according to the protocol approved by the Medical
Ethics Committee (MEC-2011-450) of the Erasmus University
Medical Center Rotterdam.
Seventeen samples (from 14 patients) contained OCSCC and
non-tumorous tissue (i.e. surface squamous epithelium, CT, mus-
cle, adipose tissue, gland and nerve). These samples were har-
vested from the fresh resection specimens, from a region with
macroscopically visible tumor. The other 27 samples (from 19
patients) contained only non-tumorous tissue and were harvested
from 2 locations: (1) 14 samples (from 12 patients) were taken
from the resection specimen within a macroscopically normal-
appearing region adjacent to the tumor, and (2) 13 samples (from
13 patients) were taken from the contralateral (not-affected) edge
of the tongue.
All samples were at least 5  5 mm in size. Samples from the
surgical resection specimens were taken within 60 min after
surgical excision. Contralateral samples were taken during
surgery. The samples were snap frozen by immersion in isopen-
tane and subsequently in liquid nitrogen, and kept at 80 C until
further use.Raman spectroscopic mapping experiments and annotated reference
spectra
The frozen tissue samples were mounted on a cryotome stage
using CryoCompound (KP-CryoCompound, Klinipath B.V., The
Netherlands), and 20 lm thick frozen tissue sections were cut,
placed on fused silica windows and allowed to dry at room temper-
ature. Raman mapping experiments were performed, using a Spec-
traCell RA Bacterial Strain Analyzer (RiverD International B.V.,
Rotterdam, The Netherlands). This instrument was designed as a
fully automated inverted confocal Raman microscope for analyzing
bacterial samples. After modification of the software it was used
for point-by-point Raman mapping of tissue sections.
The data processing and data analysis has been described in
detail previously [31]. The data analysis software was developed
in-house and operates in a MATLAB environment (MATLAB 7.5.0
(R2007b), MathWorks, MA, USA) with the multivariate toolbox
PLS-toolbox 7.0.0c (EigenVector Research, WA, USA).
Briefly, about 100 mW of laser light (785 nm) was focused to a
spot of 2 lm in diameter on the unfixed, unstained 20 lm thick
frozen tissue sections. Selected regions were scanned point-by-
point in a 2-dimensional grid with a step size of 5 lm and a spec-
tral resolution of 8 cm1. Of each point a single spectrum was
obtained, constricted to the wavenumber range of 400–
1800 cm1. The spectra were grouped using K-means Cluster Anal-
ysis (KCA) [32]. By assigning a color to each K-means cluster,
pseudo-color Raman images were generated. After the Raman
experiments tissue sections were stained with Haematoxylin and
Eosin (H&E) [33]. Comparison of these pseudo-color Raman images
with the H&E-stained tissue sections enabled histopathological
annotation of the K-means cluster averages as {1} OCSCC, {2} sur-
face squamous epithelium, {3} CT, {4} muscle, {5} adipose tissue,
{6} gland or {7} nerve, as described in detail previously [31]. With
OCSCC the epithelial (keratinocytic) component of the tumor is
meant. Based on the observed histopathological heterogeneity,
the annotated reference spectra of surface squamous epithelium
were subdivided into 3 layers (basal layer, suprabasal layer and
superficial layer) and 2 epithelial subtypes (dysplastic and non-
dysplastic), as described in detail previously [30].
These histopathologically annotated K-means cluster averages
are hereafter referred to as annotated reference spectra. For further
analysis, the spectra annotated as {1} were labeled as ‘tumor’ and
the six individual non-tumorous tissues/tissue structures {2–7}
were all marked as ‘non-tumorous tissue’.
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One half of the spectral database containing annotated refer-
ence spectra of 10 patients (hereafter called the training set) was
used to develop the tissue classification models. To ensure an accu-
rate representation of all tissue structures, the training set was
created such that each tissue structure was represented in at least
three patients. For the development of tissue classification models
Principal Components Analysis (PCA) [34] was used, followed by
(hierarchical) Linear Discriminant Analysis ((h)LDA) [35].
In this study, two tissue classification models were developed
(Fig. 1).
(1) A PCA-LDAmodel ‘tumor’ (OCSCC) versus ‘non-tumorous tis-
sue’ (i.e. surface squamous epithelium, CT, muscle, adipose
tissue, gland and nerve).
(2) A two-step PCA-hLDA model ‘tumor’ versus ‘non-tumorous
tissue’. In the first step the spectra of adipose tissue and nerve
were distinguished from all the other spectra. In the second
step the spectra of surface squamous epithelium, CT, muscle
and gland were distinguished from the spectra of OCSCC.
The best model parameters were selected based on the classifi-
cation accuracy (proportion of true results (both true positives and
true negatives) of a leave one patient out (LOPO) analysis. In a
LOPO analysis the classification models are built using the data
of all patients but one, and tested on the data of the patient that
was left out.
Validation of tissue classification models
The final tissue classification models were validated using the
other half of the spectral database (hereafter called the valida-Fig. 1. Tissue classification models. (A) PCA-LDA tissue classification model ‘tumor’ ver
‘non-tumorous tissue’.tion set) that contained annotated reference spectra of the
samples of the 11 different patients not included in the training
set.
The discriminative power of the tissue classification models
was determined by a Receiver Operator Characteristic (ROC) anal-
ysis where the true positive rate (sensitivity) is plotted against the
false positive rate (1-specificity) for different values of the discrim-
ination threshold. The area under the ROC curve (AUC) is a mea-
sure of discriminatory power of the tissue classification model
[36]. The maximum value for the AUC is 1.0, thereby indicating a
(theoretically) perfect model (i.e., 100% sensitive and 100% speci-
fic). An AUC value of 0.5 indicates no discriminative value (i.e.,
50% sensitive and 50% specific) and is represented by a straight,
diagonal line extending from the lower left corner to the upper
right. There are several scales for AUC value interpretation, but
ROC curves with an AUC of >0.9 are generally interpreted as an
excellent discriminative power, an AUC between 0.8 and 0.9 as
good, between 0.7 and 0.8 as moderate and between 0.6 and 0.7
as poor [36]. The Youden index [37] is known as an optimal value
of the discrimination threshold, yielding the highest combined
sensitivity and specificity. However, the discrimination threshold
can be chosen along the ROC curve, such that it provides the com-
bination of sensitivity and specificity that is of greatest clinical
value.Tumor-heat maps
From the PCA-(h)LDA model predictions a posterior probability
of being tumor was calculated for each individual point spectrum
of each map. By coding this probability as a color between yellow
and red, a heat map was generated for each measured Raman
map.sus ‘non-tumorous tissue’. (B) PCA-hLDA tissue classification model ‘tumor’ versus
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Characteristics of the training set
The training set consisted of 127 Raman maps, obtained from
25 tissue samples from 10 patients. Of these 25 samples, 11 sam-
ples contained OCSCC as well as surrounding non-tumorous tissue
structures (i.e. surface squamous epithelium, CT, muscle, adipose
tissue, gland and nerve), and 14 samples contained non-
tumorous tissue structures only. From the 14 tumor free samples,
8 originated from the resection specimen from a region with
macroscopically normal-appearing mucosa adjacent to the tumor,
and 6 from the contralateral (not-affected) edge of the tongue.
The scanned areas ranged in size between 250 lm  250 lm and
1005 lm x 470 lm. With a Raman measurement step size of
5 lm this resulted in 2700–18,894 point spectra per Raman map
(mean number of spectra per map: 11,421). The optimal number
of K-means clusters per map varied between 4 and 20.
In total 88 K-means clusters averages were annotated as ‘tu-
mor’, and 632 K-means clusters averages were annotated as ‘non-
tumorous tissue’ (140 surface squamous epithelium, 396 CT, 41
muscle, 33 adipose tissue, 17 gland and 5 nerve).
Characteristics of the validation set
The tissue classification models were validated using an inde-
pendent dataset. This validation set consisted of 70 Raman maps,Fig. 2. Receiver Operator Characteristic (ROC) analysis. Sensitivity is plotted against
1-specificity. The area under the ROC curve (AUC) is a measure of the discriminatory
power of the classification models. Gray line: PCA-LDA model (‘tumor’ versus ‘non-
tumorous tissue’). Black line: 2-step PCA-hLDA model (‘tumor’ versus ‘non-
tumorous tissue’).
Table 1
Misclassifications. Per tissue classification model the maximum accuracy, sensitivity (tr
threshold is chosen such that a 100% sensitivity is obtained. The number of misclassified
‘Tum
Maximum
accuracy
Sensitivity Specificity OCS
Model 1: PCA-LDA
‘tumor’ versus ‘non-tumorous
tissue’
86% 100% 66% 0/54
Model 2: PCA-hLDA
‘tumor’ versus ‘non-tumorous
tissue’
91% 100% 78% 0/54obtained from 19 samples from 11 patients that were not included
in the training set. Of these 19 tissue samples, 6 samples contained
OCSCC as well as surrounding non-tumorous tissue structures (i.e.
surface squamous epithelium, CT, muscle, adipose tissue, gland
and nerve), and 13 samples contained non-tumorous tissue struc-
tures only. From the 13 tumor free samples, 6 originated from the
resection specimen from a region with macroscopically normal-
appearing mucosa adjacent to the tumor, and 7 from the contralat-
eral (not-affected) edge of the tongue. The scanned areas ranged in
size between 250 lm  100 lm and 1005 lm  420 lm. With
a Raman measurement step size of 5 lm this resulted in
1050–16,884 point spectra per Raman map (mean number of
spectra per map: 9620). The optimal number of K-means clusters
per map varied between 3 and 19.
In total 54 K-means clusters averages were annotated as
‘tumor’, and 313 K-means clusters averages were annotated as
‘non-tumorous tissue’ (62 surface squamous epithelium, 185 CT,
20 muscle, 32 adipose tissue, 9 gland and 5 nerve).Validation of the tissue classification models
All results shown were generated using the validation set. Ini-
tially, a PCA-LDA model was built to distinguish ‘tumor’ from
‘non-tumorous tissue’ (i.e. surface squamous epithelium, CT, mus-
cle, adipose tissue, gland and nerve). This model used five principal
components (PCs) and showed a maximum classification accuracy
of 86%. The ROC analysis showed an area under the ROC curve
(AUC) of 0.90 (Fig. 2). At a sensitivity of 100%, specificity reached
66%. The misclassifications with this discrimination threshold
occurred for surface squamous epithelium (58/62), CT (11/185),
muscle (15/20), adipose tissue (16/32), gland (4/9) and nerve
(3/5) (Table 1).
Since previous published results indicated that certain individ-
ual non-tumorous tissue structures were easier to distinguish from
OCSCC than others [30], a PCA-hLDA model with two consecutive
steps was built. In the first step the spectra of adipose tissue and
nerve were distinguished from all the other spectra, using three
PCs. In the second step the spectra of surface squamous epithelium,
CT, muscle and gland were distinguished from the spectra of
OCSCC, with an optimal number of 11 PCs. This model showed a
maximum classification accuracy of 91%. The ROC analysis resulted
in an AUC of 0.95 (Fig. 2). At a sensitivity of 100% this model
yielded a specificity of 78%. The misclassifications with this dis-
crimination threshold occurred for surface squamous epithelium
(51/62), CT (12/185) and gland (5/9) (Table 1).
Detailed histopathological evaluation of the misclassified sur-
face squamous epithelium spectra revealed that 30 of the 32 spec-
tra annotated as dysplastic epithelium were misclassified.
Furthermore, all spectra (23/23) annotated as basal epithelial lay-
ers were misclassified. Analysis of the CT misclassifications showed
that all misclassified CT spectra (12/12) were obtained from tissue
samples containing OCSCC; i.e. from peritumoral stroma.ue positive rate) and specificity (true negative rate) are shown. The discrimination
spectra per tissue structure have been further detailed in the last 7 columns.
or’ ‘Non-tumorous tissue’
CC Surface squamous
epithelium
CT Muscle Adipose
tissue
Gland Nerve
58/62 11/185 15/20 16/32 4/9 3/5
51/62 12/185 0/20 0/32 5/9 0/5
Fig. 3. Tumor-heat maps. Results of the two tissue classification models are shown. The H&E stained tissue section (A) shows areas with OCSCC and surrounding CT and (D)
shows non-tumorous tissue (CT: connective tissue, M: muscle and A: adipose tissue). Posterior probability of being tumor was calculated for each individual point spectrum
of each map and plotted as a color between yellow and red (B-C, E-F). (For interpretation of the references to color in this figure legend, the reader is referred to the web
version of this article.)
F.L.J. Cals et al. / Oral Oncology 60 (2016) 41–47 45Proof of principle: tumor-heat maps
To demonstrate the differences between the tissue classification
models, heat maps were made. A representative example is shown
in Fig. 3. Fig. 3A–C shows a mapped area with OCSCC and sur-
rounding non-tumorous CT. Fig. 3D–F shows non-tumorous tissue
structures only. For more examples see Supplementary Figs. S1–S3.
Discussion
Raman spectroscopy is a nondestructive, optical technique that
does not need pre-treatment or labeling to characterize tissue in
real-time [10]. This makes the technique potentially very suitable
for intra-operative application. In vivo recorded Raman spectra
from intact (bulk) tissue will contain spectroscopic features from
all histological structures and layers present in the entire illumi-
nated volume [25]. To provide a solid foundation for the develop-
ment of a diagnostic tool, spectroscopic knowledge about the
entire target volume is mandatory. We therefore focus on the indi-
vidual spectroscopic features of all histological structures present
in tongue tissue. In previous work we investigated the potential
of Raman spectroscopy for tongue cancer detection, by distinction
between OCSCC spectra and spectra of individual non-tumorous
tissue structures [26]. In this study, we used this knowledge to
develop and validate ‘tumor’ versus ‘non-tumorous tissue’ classifi-
cation models.
The use of Raman spectroscopy for characterization of normal
and malignant tongue tissue was demonstrated by several author
[24,26,38], but an independently validated tissue classificationmodel that distinguishes OCSCC from non-tumorous tongue tissue
has not been published before. Singh et al. described a tumor clas-
sification model for another oral cavity subsite: buccal mucosa
[39]. They performed ex vivo measurements on intact (bulk) buccal
mucosa samples. With their validated PCA-LDA tissue classification
model, 87% overall accuracy was obtained when discriminating
tumor tissue-spectra from normal tissue-spectra [39]. Although
Raman results of different oral cavity subsites can show inherent
spectral differences [40], the accuracy of this buccal model and
our tongue PCA-LDA tissue classification model was comparable.
The higher accuracy (of 91%) of our second model can be explained
by the use of a multi-step hierarchical LDA. This proved to be more
effective than a single step PCA-LDA model in the discrimination
between ‘tumor’ and ‘non-tumorous tissue’. The reason for this,
is that in an PCA-hLDA model each discrimination step can be opti-
mized separately [35].
Compared to tissue classification models that are based on
intact (bulk) tissue measurements our method uses the spectra
of individual tissue structures. This makes it possible to explore
the misclassifications of the developed models in detail and gain
insight in their clinical relevance. All spectra annotated as basal
epithelial layers were misclassified as tumor. This is not surprising
because OCSCC originates from the surface squamous epithelium.
In carcinogenesis, stem cells located in the basal epithelial layers
acquire genetic alterations, followed by clonal expansion [41]. This
explains the similarity in biochemical composition (and thus
Raman spectra) of surface squamous epithelium and OCSCC. How-
ever, it is important to underline that the misclassifications of sur-
face squamous epithelium spectra do not compromise the clinical
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positive resections margins are located in the deeper soft tissue
layers [8], because tumor at the epithelium surface is visible and
therefore often adequately resected. A Raman signature resem-
bling squamous epithelium found in the deeper soft tissue is auto-
matically suspicious of OCSCC.
In total 6.8% (17/251) of the non-tumorous tissue spectra that
were obtained in the deeper soft tissue layers were misclassified.
The majority (12/251) represented CT spectra that were obtained
in the proximity (<5 mm) of the tumor (also referred to as ‘peritu-
moral stroma’). This might be explained by micro-environmental
stromal changes that occur around a tumor. Tumor development
is accompanied by an immune response that leads to tumor infil-
tration by inflammatory cells [42] and neo-angiogenesis [43].
Hereby the biochemical composition of ‘peritumoral stroma’ dif-
fers from that of CT at a greater distance to the tumor. Though,
these CT misclassifications are neither of clinical concern. In
respect to the surgical aim which is to remove the tumor with an
adequate margin of at least 5 mm of non-tumorous surrounding
tissue, these false-positive classified spectra would in clinical prac-
tice not result in unnecessary resection of healthy tissue.
The developed PCA-hLDA classification model could directly be
used for objective and automated assessment of frozen tissue sec-
tions. Unfortunately, current Ramanmapping experiments take too
much time to replace the routine frozen tissue section procedure.
In our study, the scanning step size of 5 lm was chosen to obtain
molecular information on a (sub)cellular level. Investigation of the
detection limit (minimum amount of tumor cells necessary to be
detected as tumor) will define whether this step size can be
increased to reduce the measurement time without the loss of
information. Furthermore, there are several other approaches pro-
posed to reduce the current measurement time. Takamori et al.
showed that the total mapping time was reduced by the combina-
tion of Raman spectroscopy with auto-fluorescence [44]. Auto-
fluorescence, which has a high sensitivity and speed but low speci-
ficity, was used to identify the areas in a tissue section that were
suspicious for tumor and needed further detailed classification by
Raman spectroscopy.
Use of intact fresh tissue (without making frozen sections) is
another way to speed up the evaluation time, as described by Kong
et al. [45]. They also used a combination of Raman spectroscopy
and auto-fluorescence, and demonstrated that an objective diagno-
sis of basal cell carcinoma was provided for unsectioned tissue
layers, faster than conventional histopathology and without the
need for sample preparation. With this reduced measurement time
intra-operative evaluation of all resection margins on the surgical
specimen and/or in the wound bed is more achievable.
The classification model with an AUC of 0.95 from this study is
the basis for further development of a Raman-spectroscopic diag-
nostic tool which can intra-operatively guide the surgeon to
achieve adequate resection margins. Such tool can add to surgeon’s
experience (based on the visual inspection and palpation). The cut-
off values of desired sensitivity and specificity may vary depending
on the a-priori probability of suspicious tissue being tumor. Lower
sensitivity and thus higher specificity may be accepted when a sus-
picious tissue to be resected had as low a-priori probability, com-
bined with an expected functional loss or extended reconstruction.
In this study we developed and validated Raman spectroscopy-
based in vitro tissue classification models for discrimination
between OCSCC and (subepithelial) non-tumorous tongue tissue.
A detailed analysis was made of the misclassifications to gain
insight in their clinical relevance. We conclude that the high sensi-
tivity and specificity of the PCA-hLDA classification model would
be helpful in achieving adequate resection margins and that such
clinical implementation is technically feasible.Conflict of interest
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